// App-Quantinova.ai

: DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION

Researchers

Presenter

  • Alice Yuan

Principal Investigators

  • Elizabeth Bering

  • J Gregory Cairncross

  • Michael Blough

Medical Centers

  • University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • MutL Homolog 1

  • MutS Homolog 6

  • MutS protein homolog 2

  • Cluster of Differentiation 206

  • Poly(ADP-Ribose) Polymerase 1

Drug/Treatment

  • Temozolomide

  • Veliparib

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved